Register Log-in Investor Type


QuotedData’s morning briefing 26 April 2023

  • RTW Venture Fund Limited announced that Abdera Therapeutics has completed its $142M Series A and Series B financing rounds in which it participated. Abdera is a privately held pre-clinical stage biopharmaceutical company leveraging antibody engineering to design and develop new precision radiopharmaceuticals for cancer. The company is building a pipeline of potentially best-in-class therapies for both clinically validated and novel targets that deliver potent radioisotopes capable of emitting alpha or beta particles to selectively destroy cancer cells.
  • Greencoat UK Wind PLC announced that it has published its ESG Report for 2022 which is available on the company’s website.

We also have a trading update from Oakley Capital, and CT Property Trust, and annual results for Aquila European Renewables, RM Infrastructure Income, M&G Credit Income, and Third Point Investors

Leave a Reply

Your email address will not be published. Required fields are marked *

Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.

You live in…

You are a…